Tuesday, November 13, 2012
Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial. Edison Press Release, November 13, 2012, Rev. FINAL
Role of DNA Polymerases in Repeat-Mediated Genome Instability.
Role of DNA Polymerases in Repeat-Mediated Genome Instability. Shah KA, Shishkin AA, Voineagu I, Pavlov YI, Shcherbakova PV, Mirkin SM.; Cell Rep. 2012 Nov 7. doi: 10.1016/j.celrep.2012.10.006
OPEN ACCESS
FULL TEXT PDF
OPEN ACCESS
FULL TEXT PDF
Subscribe to:
Posts (Atom)